Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells (Panc-1)
AUTOR(ES)
Zhu, Xiang-Yu, Liu, Ning, Liu, Wei, Song, Shao-Wei, Guo, Ke-Jian
FONTE
Genetics and Molecular Biology
DATA DE PUBLICAÇÃO
17/05/2012
RESUMO
Integrin-linked kinase (ILK) is an ankyrin repeat-containing serine-threonine protein kinase that is involved in the regulation of integrin-mediated processes such as cancer cell proliferation, migration and invasion. In this study, we examined the effect of a lentivirus-mediated knockdown of ILK on the proliferation, migration and invasion of pancreatic cancer (Panc-1) cells. Immunohistochemical staining showed that ILK expression was enhanced in pancreatic cancer tissue. The silencing of ILK in human Panc-1 cells led to cell cycle arrest in the G0/G1 phase and delayed cell proliferation, in addition to down-regulating cell migration and invasion. The latter effects were mediated by up-regulating the expression of E-cadherin, a key protein in cell adhesion. These findings indicate that ILK may be a new diagnostic marker for pancreatic cancer and that silencing ILK could be a potentially useful therapeutic approach for treating pancreatic cancer.
Documentos Relacionados
- Inhibition of Integrin-Linked Kinase Attenuates Renal Interstitial Fibrosis
- Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells
- Integrin-Linked Kinase Regulates Endothelial Cell Survival and Vascular Development
- Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways
- RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells